Latest Articles

Publication Date
Tellimagrandin II Stimulates Inflammasomes by Causing an Accumulation of 3-Aminopropanal, Which Promotes Apoptosis of Endometriotic Cells While Inhibiting Invasion.

Endometriosis is frequently treated with Paeoniae Radix. It contains Tellimagrandin II, which has the role of modulating immunity and anti-tumor. Therefore, we will explore the effects of Tellimagrandin II on …

Published: Dec. 29, 2025, midnight
Nerve-adjacent endometriosis mimicking a suprapubic nerve sheath tumor: illustrative case.

Endometriosis is a chronic gynecological disorder characterized by ectopic endometrial tissue, commonly affecting pelvic structures. Rarely, it occurs in extrapelvic locations, mimicking other pathologies and posing diagnostic challenges.

Published: Dec. 29, 2025, midnight
Mali Barbi: Moving Beyond the “One-Size-Fits-All” Era in Endometrial Cancer - Oncodaily

Mali Barbi: Moving Beyond the “One-Size-Fits-All” Era in Endometrial Cancer Oncodaily

Published: Dec. 27, 2025, 7:14 p.m.
Endometrial Cancer: Toxicity Management and Treatment Persistence with Lenvatinib-Pembrolizumab - OncLive

Endometrial Cancer: Toxicity Management and Treatment Persistence with Lenvatinib-Pembrolizumab OncLive

Published: Dec. 26, 2025, 1:19 p.m.
Endometrial Cancer: Counseling on dMMR vs pMMR - Explaining Survival Advantage and Clinical Expectations - OncLive

Endometrial Cancer: Counseling on dMMR vs pMMR - Explaining Survival Advantage and Clinical Expectations OncLive

Published: Dec. 26, 2025, 1:19 p.m.
After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... - MSN

After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... MSN

Published: Dec. 25, 2025, 7:50 p.m.
Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals.

Endometriosis is a highly prevalent, chronic gynecological disorder characterized by the ectopic presence of endometrial-like tissue, driving significant morbidity and chronic pelvic pain. Pathologically, it is increasingly recognized as a …

Published: Dec. 25, 2025, midnight
Study Explores DPP4’s Role in Ferroptosis and Endometrial Receptivity in PCOS Patients - geneonline.com

Study Explores DPP4’s Role in Ferroptosis and Endometrial Receptivity in PCOS Patients geneonline.com

Published: Dec. 24, 2025, midnight
Molecular and Immune Microenvironmental Changes Across Endometrial Lesions: A Comprehensive Immunohistochemical and Clinical Analysis of Progression From Benignity to Carcinoma.

Adenomyosis and endometriosis are estrogen-driven disorders with a recognized potential for malignant transformation, particularly through atypical endometriosis. The molecular and immune mechanisms underlying this progression remain incompletely understood. However, clinical …

Published: Dec. 24, 2025, midnight
Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS - BIOENGINEER.ORG

Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS BIOENGINEER.ORG

Published: Dec. 23, 2025, 7:31 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!